Methods and compositions for treatment of mydriasis
Grant
US12576067B2
Kind: B2
Mar 17, 2026
Assignee
Opus Genetics, Inc.
Inventors
Mina Sooch, Alan R. Meyer, Konstantinos Charizanis, Bernhard Hoffmann, William H. Pitlick
Abstract
The invention provides methods, compositions, and kits containing an alpha-adrenergic antagonist, such as phentolamine, for use in monotherapy or as part of a combination therapy to treat patients suffering from presbyopia, mydriasis, and/or other ocular disorders.
CPC Classifications
A61K 2300/00
A61K 31/417
A61K 31/4178
A61K 31/498
A61K 9/0048
A61K 45/06
A61K 47/12
A61K 47/26
A61K 9/08
A61P 27/08
A61P 27/10
A61P 27/06
Filing Date
2025-01-17
Application No.
19029592
Claims
54